Bridgewater Advisors Inc. Astrazeneca PLC Transaction History
Bridgewater Advisors Inc.
- $1.37 Billion
- Q3 2025
A detailed history of Bridgewater Advisors Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Bridgewater Advisors Inc. holds 10,619 shares of AZN stock, worth $949,338. This represents 0.06% of its overall portfolio holdings.
Number of Shares
10,619
Previous 10,459
1.53%
Holding current value
$949,338
Previous $730,000
11.51%
% of portfolio
0.06%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...